BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16310487)

  • 1. Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
    Saito W; Kase S; Yoshida K; Ohguro H; Yokoi M; Iwaki H; Ohno S
    Am J Ophthalmol; 2005 Nov; 140(5):942-5. PubMed ID: 16310487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
    Ohguro H; Ogawa K; Nakagawa T
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
    Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunologic aspects of cancer-associated retinopathy.
    Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
    Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kiloDalton.
    Parc CE; Azan E; Bonnel S; Sahel JA; Kaplan J; Thirkill CE
    Ophthalmic Genet; 2006 Jun; 27(2):57-61. PubMed ID: 16754207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
    Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.
    Maeda A; Ohguro H; Maeda T; Wada I; Sato N; Kuroki Y; Nakagawa T
    Cancer Res; 2000 Apr; 60(7):1914-20. PubMed ID: 10766180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral diffuse melanocytic proliferation associated with ovarian carcinoma and metastatic malignant amelanotic melanoma.
    Duong HV; McLean IW; Beahm DE
    Am J Ophthalmol; 2006 Oct; 142(4):693-5. PubMed ID: 17011873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroidal neovascularization associated with cancer-associated retinopathy.
    Querques G; Thirkill CE; Hagege H; Soubrane G; Souied EH
    Acta Ophthalmol; 2010 Aug; 88(5):571-5. PubMed ID: 19141145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carcinoma-associated retinopathy: a review with clinical examples].
    Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferior peripheral nonperfusion in bilateral diffuse uveal melanocytic proliferation.
    Yonekawa Y; Shildkrot Y; Eliott D
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):190-2. PubMed ID: 23510044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
    Adamus G; Ren G; Weleber RG
    BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral diffuse uveal melanocytic proliferation simulating an arteriovenous fistula.
    Murphy MA; Hart WM; Olk RJ
    J Neuroophthalmol; 1997 Sep; 17(3):166-9. PubMed ID: 9304528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bilateral diffuse uveal melanocytic proliferation associated with systemic carcinoma: two case reports].
    Frau E; Lautier-Frau M; Labetoulle M; Kirch O; Rumen F; Cardine S; Offret H
    J Fr Ophtalmol; 2002 Dec; 25(10):1032-5. PubMed ID: 12527827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral diffuse uveal melanocytic proliferation and uterine cancer. A case report.
    Ritland JS; Eide N; Tausjø J
    Acta Ophthalmol Scand; 2000 Jun; 78(3):366-8. PubMed ID: 10893075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer associated retinopathy (CAR). Two clinical cases and review of the literature].
    Matus G; Dicato M; Focan C
    Rev Med Liege; 2007 Mar; 62(3):166-9. PubMed ID: 17511385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution OCT imaging of RPE degeneration in bilateral diffuse uveal melanocytic proliferation.
    Besirli CG; Comer GM
    Ophthalmic Surg Lasers Imaging; 2010; 41 Suppl():S96-S100. PubMed ID: 21117612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated retinopathy in patients with breast carcinoma.
    Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
    Murphy MA; Thirkill CE; Hart WM
    J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.